Susquehanna analyst issues NEUTRAL recommendation for HES on July 22, 2024 08:50AM ET. The previous analyst recommendation was Neutral.HES was trading at $151.47 at issue of the analyst recommendation.The overall...
Susquehanna analyst issues POSITIVE recommendation for MRO on July 22, 2024 08:51AM ET. The previous analyst recommendation was Positive.MRO was trading at $28.61 at issue of the analyst recommendation.The overall...
Evercore ISI analyst issues OUTPERFORM recommendation for SLB on July 22, 2024 08:35AM ET. The previous analyst recommendation was Outperform.SLB was trading at $49.38 at issue of the analyst recommendation.The...
Piper Sandler analyst issues OVERWEIGHT recommendation for HAL on July 22, 2024 07:04AM ET. The previous analyst recommendation was Overweight.HAL was trading at $34.4 at issue of the analyst recommendation.The...
Cowen & Co. analyst issues BUY recommendation for SLB on July 22, 2024 07:19AM ET. The previous analyst recommendation was Buy.SLB was trading at $49.67 at issue of the analyst...
Wells Fargo analyst issues OVERWEIGHT recommendation for FANG on July 18, 2024 06:15AM ET. The previous analyst recommendation was Overweight.FANG was trading at $210.94 at issue of the analyst recommendation.The...
Piper Sandler analyst issues OVERWEIGHT recommendation for FANG on July 18, 2024 06:39AM ET. The previous analyst recommendation was Overweight.FANG was trading at $210.94 at issue of the analyst recommendation.The...
Wolfe Research analyst issues OUTPERFORM recommendation for XOM on July 17, 2024 04:41PM ET. XOM was trading at $117.64 at issue of the analyst recommendation.The overall analyst consensus : BUY.Current...
Wolfe Research analyst issues OUTPERFORM recommendation for XOM on July 17, 2024 04:41PM ET. XOM was trading at $117.64 at issue of the analyst recommendation.The overall analyst consensus : BUY.Current...
Wolfe Research analyst issues OUTPERFORM recommendation for BP on July 17, 2024 04:09PM ET. BP was trading at $35.42 at issue of the analyst recommendation.The overall analyst consensus : BUY.Current...
